Articles From: Course Hero Secures $15 million in Series A Funding; Investors include GSV Capital and IDG Capital to Enanta Announces Results from TURQUOISE-I Study in Chronic Hepatitis C Patients with HIV-1 Co-infection and from the CORAL-I Study In Liver Transplant Recipients at The Liver Meeting 2014®


2014/11/11
REDWOOD CITY, Calif., Nov.
Sign-up for Course Hero Secures $15 million in Series A Funding; Investors include GSV Capital and IDG Capital investment picks
Cracker Barrel Old Country Store, Inc. (“the “Company”) (Nasdaq:CBRL) will provide an online, real-time Webcast and rebroadcast of its first quarter earnings conference call on Tuesday, November 25, beginning at 11:00 a.m. Eastern Time.
Sign-up for Cracker Barrel Fiscal 2015 First Quarter Conference Call on the Internet investment picks
2014/11/11
BUENOS AIRES, Argentina , Nov.
Sign-up for Cresud S.A.C.I.F. y A. Announces Results for the First Quarter 2015 Ended September 2014 investment picks
CSG International ( NASDAQ: CSGS ), a global provider of interactive transaction-driven solutions and services, today released results of its new survey, “ Delivering a Differentiated Customer Experience in the Home ,” that explores the ways consumers want to be engaged before, during, and after service installation or a technician appointment.
Sign-up for CSG Releases Survey Results on In-Home Customer Service investment picks
2014/11/11
CHARLOTTE, N.C., Nov.
Sign-up for Curtiss-Wright Declares Dividend of $0.13 Per Share for Common Stock investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G026019-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/10/11G026019/8b7f50fa9ea04adf_org-744441779.jpg WYOMISSING, PA--(Marketwired - November 11, 2014) - Customers Bancorp, Inc. (NASDAQ: CUBI), the parent company of Customers Bank (collectively "Customers"), today announced that it will attend one-on-one meetings with investors at the Sandler O'Neill East Coast Financial Services Conference to be held in Naples, Florida on November 13th, 2014.
Sign-up for Customers Bancorp, Inc. to Participate at the Sandler O'Neill East Coast Financial Services Conference November 13, 2014 investment picks
BERKELEY HEIGHTS, N.J., Nov.
Sign-up for Cyclacel Pharmaceuticals Reports Third Quarter 2014 Financial Results investment picks
2014/11/11
Sign-up for D.R. Horton's profit rises, but falls short of expectations investment picks
2014/11/11
4th Annual Talkin' Cloud 100 Report Identifies Top Cloud Computing Companies TORONTO and LAKE MARY, FL , Nov.
Sign-up for D+H Ranked 14th Among World's Top 100 Cloud Services Providers investment picks
BROOKINGS, S.D., Nov.
Sign-up for Daktronics, Inc. to Release Second Quarter 2015 Financial Results investment picks
Teammates across the country celebrate and commemorate veteran military personnel for Veterans Day DENVER , Nov.
Sign-up for DaVita HealthCare Partners Honors and Supports Service Members investment picks
Delphi Automotive PLC (NYSE:DLPH) will present at the Goldman Sachs Industrials Conference on November 12 th in Boston.
Sign-up for Delphi to Present at the Goldman Sachs Industrials Conference Wednesday investment picks
Demandware ®, Inc. (NYSE: DWRE), the industry-leading provider of enterprise cloud commerce solutions, today announced that the company will present at the following conference: UBS Global Technology Conference Tim Adams, Demandware Chief Financial Officer, will present on Thursday, November 20 th at 8:30 a.m. PST at Cavallo Point, The Lodge at the Golden Gate An audio webcast of the presentation will be available on Demandware’s investor relations website at http://investors.demandware.com .
Sign-up for Demandware Executive to Present at Upcoming Investor Conference investment picks
2014/11/11
DeVry Education Group (NYSE:DV), a global provider of educational services, announced today with great sadness the death of Dr.
Sign-up for DeVry Education Group Announces Death of Board Chair Connie Curran investment picks
PITTSBURGH , Nov.
Sign-up for DICK'S Sporting Goods Third Quarter Results Call Scheduled for November 18th investment picks
Zayo Group, LLC (“Zayo”), an international provider of Bandwidth Infrastructure services, today announced an alliance agreement with Digital Realty (NYSE: DLR) to expand the Digital Realty direct connect cloud offering.
Sign-up for Digital Realty Data Centers to Offer Cloud Connectivity through Zayo investment picks
2014/11/11
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978401001&sourceType=1 http://media3.marketwire.com/logos/20140717-DREAM%20INDUSTRIAL%20200.jpg TORONTO, ONTARIO --
Sign-up for Dream Industrial Reports 7.4% Growth in Year-to-Date AFFO per Unit and Announces the Appointment of New President and Chief Executive Officer investment picks
2014/11/11
South Florida clinic will revolutionize the hair loss industry.
Sign-up for DS Healthcare Group to open first hair loss clinic in the U.S. investment picks
COLUMBUS, Ohio , Nov.
Sign-up for DSW Inc. Announces Earnings Release Date for Third Quarter 2014 Results investment picks
CUPERTINO, Calif.
Sign-up for DURECT Provides Update on POSIDUR™ Program investment picks
HAIFA, Israel , November 11, 2014 /PRNewswire/ -- Elbit Systems Ltd.
Sign-up for Elbit Systems U.S. Subsidiary Awarded Approximately $29 Million Contract to Provide Logistics Support to the United States Air Force's F-16 Head-Up Displays investment picks
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced detailed results from AbbVie’s open-label, Phase 2b PEARL-I study in patients with genotype 4 (GT4) chronic hepatitis C virus (HCV). PEARL-I studied AbbVie’s all-oral, interferon-free investigational treatment combining two direct-acting antivirals (ABT-450/ritonavir and ombitasvir) with or without ribavirin (RBV) for 12 weeks in non-cirrhotic adult patients with chronic genotype 1b (GT1b) and GT4 hepatitis C virus (HCV) infection.
Sign-up for Enanta Announces Results from Phase 2b PEARL-I Study in Genotype 4 Chronic Hepatitis C Patients at The Liver Meeting 2014® investment picks
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced at The Liver Meeting ® 2014 results from studies in chronic hepatitis C virus (HCV) patients with human immunodeficiency virus type 1 (HIV-1) co-infection (TURQUOISE-I) and liver transplant recipients (CORAL-I). New, detailed results from part one of the Phase 2 portion of AbbVie’s Phase 2/3 open-label study, TURQUOISE-I, showed that patients co-infected with genotype 1 (GT1) HCV and HIV-1 receiving AbbVie’s investigational treatment and ribavirin (RBV) for 12 weeks or 24 weeks achieved a sustained virologic response rate 12 weeks post-treatment (SVR 12 ) of 93.5 percent (n=29/31) and 90.6 percent (n=29/32), respectively.
Sign-up for Enanta Announces Results from TURQUOISE-I Study in Chronic Hepatitis C Patients with HIV-1 Co-infection and from the CORAL-I Study In Liver Transplant Recipients at The Liver Meeting 2014® investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Course Hero Secures $15 million in Series A Funding; Investors include GSV Capital and IDG Capital to Enanta Announces Results from TURQUOISE-I Study in Chronic Hepatitis C Patients with HIV-1 Co-infection and from the CORAL-I Study In Liver Transplant Recipients at The Liver Meeting 2014®
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent